BIOCRYST PHARMACEUTICALS INC (BCRX)

US09058V1035 - Common Stock

7.83  +0.13 (+1.69%)

After market: 7.87 +0.04 (+0.51%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
412.58M331.41M270.80M157.20M17.80M
Cost Of Goods
7.99M4.66M6.60M7.30M1.70M
Gross Profit
404.59M326.75M264.20M149.90M16.10M
Operating Expenses
445.29M428.91M412.70M327.60M190.90M
Research and Development
195.25M215.02M253.30M208.80M123.00M
Selling, General, and Administrative Expenses
250.04M213.89M159.40M118.80M67.90M
Operating Income
-40.70M-102.16M-148.40M-177.70M-174.80M
Interest Income/Expense
-83.42M-93.50M-95.90M-59.90M-6.00M
Non Recurring Items
N/A-30.57M0.0055.80M-2.00M
Income Before Taxes
-124.13M-226.23M-244.40M-181.80M-182.80M
Income Tax
-308.00K310.00K2.70M2.30MN/A
Net Income
-123.82M-226.54M-247.10M-184.10M-182.80M
EBITDA
-39.34M-100.51M-146.96M-176.92M-174.05M
 
Per Share Data
EPS Diluted Total Ops
-0.61-1.18-1.33-1.03-1.09
Non GAAP EPS
-0.58-0.99-1.33-1.03-1.08
 
Statistics
Gross Profit Margin
98.06%98.59%97.56%95.36%90.45%
Profit Margin
-30.01%-68.36%-91.25%-117.11%-1026.97%
Operating Profit Margin
-9.87%-30.83%-54.80%-113.04%-982.02%

All data in USD

Charts